Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mass Screening × Gastrointestinal × 30 days × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1 Gynecologic 1 Gastrointestinal 1

Conditions

Esophageal Neoplasms 1

Interventions

Oxaliplatin 67 Fluorouracil 65 Specimen Handling 58 Bevacizumab 53 pembrolizumab 52 Leucovorin 47 Magnetic Resonance Spectroscopy 40 Gemcitabine 40 Biopsy 34 Nivolumab 33 Capecitabine 32 Irinotecan 30 Cetuximab 30 Cisplatin 29 durvalumab 24 130-nm albumin-bound paclitaxel 24 Paclitaxel 23 atezolizumab 18 Folfox protocol 18 dehydroftorafur 17 Carboplatin 17 Drug Therapy 15 Albumin-Bound Paclitaxel 15 Trastuzumab 13 Radiotherapy 13 Cyclophosphamide 12 trifluridine tipiracil drug combination 11 tislelizumab 11 X-Rays 11 Taxes 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06335966 2026-03-17

BEST-RPP

OHSU Knight Cancer Institute

Active not recruiting

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡